Tom Dotter, DBA, is an accomplished healthcare executive with extensive experience in oncology and rare diseases, currently serving as the Oncology Business Director for Incyte since July 2021. Dotter has a proven track record of leading sales teams, developing strategic initiatives, and executing successful product launches across various therapeutic areas, including multiple sclerosis and hematology. Prior roles include senior positions at Daiichi Sankyo, Novartis, Genzyme, and Merck, where Dotter demonstrated expertise in team development, account management, and market strategy execution. Educational qualifications include an MBA from Baylor University and a Doctor of Business Administration from the University of the Incarnate Word.
This person is not in the org chart
This person is not in any teams
This person is not in any offices